Clinical Trial Update: A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy® [Phase 3]

View source ↗

Summary

A Phase III clinical trial update evaluating weight loss from semaglutide injection and Wegovy in obesity. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Semaglutide injection (semaglutide)
• WEGOVY (Semaglutide)

Snippet

Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Conditions: Obesity | Phase 3 | Status: NOT_YET_RECRUITING